51165-05-0
51165-05-0
Chemical Structure
Substance P (7-11)
- CAS No.: 51165-05-0
- Formula:C31H44N6O5S
- Molecular Weight:612.78
IUPAC Name: (S)-2-(2-((S)-2-((S)-2-amino-3-phenylpropanamido)-3-phenylpropanamido)acetamido)-N-((S)-1-amino-4-(methylthio)-1-oxobutan-2-yl)-4-methylpentanamide
InChIKey: RBKYMAQIAMFDOE-CQJMVLFOSA-N
SMILES: CSCC[C@@H](C(N)=O)NC([C@H](CC(C)C)NC(CNC([C@H](CC1=CC=CC=C1)NC([C@H](CC2=CC=CC=C2)N)=O)=O)=O)=O
Biological Activity: Substance P (7-11) is a C-terminal fragment of Substance P which can cause an increase in the intracellular calcium concentration.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Substance P (7-11) | 99.08% | Substance P (7-11) is a C-terminal fragment of Substance P which can cause an increase in the intracellular calcium concentration. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Phe-Met-Arg-Phe, amide | Phe-Met-Arg-Phe, amide dose dependently (ED50=23 nM) activates a K+ current in the peptidergic caudodorsal neurons. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Phe-Met-Arg-Phe, amide acetate | Phe-Met-Arg-Phe, amide acetate dose dependently (ED50=23 nM) activates a K+ current in the peptidergic caudodorsal neurons. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
FMRF | 99.72% | FMRF is a peptide consisting of 4 amino acid residues. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[Met5]-Enkephalin, amide | [Met5]-Enkephalin, amide is an agonist for δ opioid receptors as well as putative ζ (zeta) opioid receptors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[D-Ala2]-Met-Enkephalinamide | 98.61% | [D-Ala2]-Met-Enkephalinamide, an opioid peptide, is a potent opioid agonist. [D-Ala2]-Met-Enkephalinamide decreases bile flow by a central mechanism. [D-Ala2]-Met-Enkephalinamide has analgesic properties. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[D-Ala2] Leu-Enkephalinamide | [D-Ala2] Leu-Enkephalinamide is an enkephalin analog. [D-Ala2] Leu-Enkephalinamide has great corneal permeability and analgesic effect. [D-Ala2] Leu-Enkephalinamide can be used for the research of ocular diseases. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[Ala2] Met-Enkephalinamide | [Ala2] Met-Enkephalinamide is an active peptide. [Ala2] Met-Enkephalinamide can be used for the research of various biochemical studies. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
[Glp6] Substance P (6-11) | [Glp6] Substance P (6-11) is an analogue of substance P (6-11). Substance P (6-11) stimulates [3H]-inositol monophosphate ([3H]-IP1) formation in rat urinary bladder by acting on the 'septide-sensitive' tachykinin receptors. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Substance P (6-11) | Substance P (6-11) is the C-terminal hexapeptideamide of Substance P (HY-P0201). Substance P (6-11) binds to NK-1 tachykinin receptor. Substance P (6-11) shows depolarization of motoneurons and a hypotensive effect. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Substance P (5-11) | Substance P (5-11), the C-terminal heptapeptide of Substance P (HY-P0201), is a neuropeptide. Substance P (5-11) binds to NK-1 tachykinin receptor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
